TAS-116
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TAS-116, covering 2024-09-04 to 2024-09-19. Get the full timeline:
Most recent: Clinical Trial Update: TAS-116 Plus Palbociclib in Breast and Rb-null Cancer [Phase 1]